Literature DB >> 29356901

Glycine enhances expression of adiponectin and IL-10 in 3T3-L1 adipocytes without affecting adipogenesis and lipolysis.

Jingqing Chen1, Xiaoshi Ma1, Ying Yang1, Zhaolai Dai1, Zhenlong Wu2,3, Guoyao Wu1,4.   

Abstract

Glycine supplementation has been reported to enhance white-fat loss and improve sensitivity to insulin in animals with obesity or type 2 diabetes. However, the underlying mechanisms responsible for the beneficial effects of glycine remain largely unknown. The purpose of this study was to test the hypothesis that glycine regulates adipocyte differentiation, adipogenesis, and lipolysis, therefore, contributing to white-fat reduction. 3T3-L1 pre-adipocytes were induced to differentiate into adipocytes in the presence of glycine (0, 0.25, 1.0, and 2.0 mmol/L) or resveratrol (50 or 100 μmol/L, served as a positive control) during the differentiation process. Hela and HepG2 cells cultured with oleic acid to induce lipid accumulation in the presence of glycine (0, 1.0, and 2.0 mmol/L) or 10 μmol/L isoproterenol (served as a positive control) for 24 h. Intracellular lipid accumulation, intracellular triglycerides, lipid droplets' diameters of mature adipocytes, mRNA, and protein levels of genes involved in the adipogenesis and lipolysis were analyzed. Isobutylxanthine-dexamethasone-insulin (MDI)-induced adipogenesis in 3T3-L1 cells were blocked by resveratrol, but not by glycine, as shown by decreased lipid contents, reduced diameters of lipid droplets, decreased protein abundances for peroxisome proliferator-activated receptor γ (PPARγ), CCAAT-enhancer-binding protein α (C/EBPα), as well as increased protein abundance of peroxisome proliferator-activated receptor coactivator-1α (PGC-1α), critical transcriptional factors that regulates adipogenesis. However, the mRNA levels of adiponectin and interleukin-10 (IL-10), two adipose-derived adipocytokines with anti-inflammatory effects, were greatly enhanced (P < 0.05) by 2 mmol/L glycine. Compared with non-treated controls, 10 μmol/L isoproterenol significantly decreased (P < 0.05) the intracellular lipid and triglyceride contents induced by oleic acid in Hela and HepG2 cells. mRNA level of fatty acid synthase (FASN), a gene involved in fatty acid synthesis, was significantly reduced (P < 0.05), while that for ATGL (adipose triglyceride lipase) and HSL (hormone-sensitive lipase), genes involved in lipolysis were significantly enhanced (P < 0.05) by isoproterenol. However, oleic acid induced the accumulation of intracellular triglyceride and lipid contents were not affected by glycine. In conclusion, glycine exposure enhanced the mRNA levels of adipose-derived adiponectin and IL-10 without affecting adipogenesis and lipolysis in 3T3-L1 adipocytes. These findings provide a possible explanation for the anti-obesity and anti-diabetic effects of glycine that were previously reported in animal models. More studies are needed to uncover the underlying mechanisms responsible for this regulatory effect of glycine on anti-inflammatory adipocytokines expression in both in vitro and in vivo models.

Entities:  

Keywords:  3T3-L1; Adipocytokine; Adipogenesis; Differentiation; Glycine; Lipolysis

Mesh:

Substances:

Year:  2018        PMID: 29356901     DOI: 10.1007/s00726-018-2537-3

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  59 in total

1.  Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes.

Authors:  Françoise Carlotti; Merlijn Bazuine; Tuija Kekarainen; Jurgen Seppen; Philippe Pognonec; J Antonie Maassen; Rob C Hoeben
Journal:  Mol Ther       Date:  2004-02       Impact factor: 11.454

Review 2.  Forming functional fat: a growing understanding of adipocyte differentiation.

Authors:  Ana G Cristancho; Mitchell A Lazar
Journal:  Nat Rev Mol Cell Biol       Date:  2011-09-28       Impact factor: 94.444

3.  Obesity and diabetes: the link between adipose tissue dysfunction and glucose homeostasis.

Authors:  Monise Viana Abranches; Fernanda Cristina Esteves de Oliveira; Lisiane Lopes da Conceição; Maria do Carmo Gouveia Peluzio
Journal:  Nutr Res Rev       Date:  2015-12       Impact factor: 7.800

4.  Glycine suppresses TNF-α-induced activation of NF-κB in differentiated 3T3-L1 adipocytes.

Authors:  Gerardo Blancas-Flores; Francisco J Alarcón-Aguilar; Rebeca García-Macedo; Julio C Almanza-Pérez; José L Flores-Sáenz; Rubén Román-Ramos; José L Ventura-Gallegos; Jesús Kumate; Alejandro Zentella-Dehesa; Miguel Cruz
Journal:  Eur J Pharmacol       Date:  2012-06-23       Impact factor: 4.432

Review 5.  Several agents and pathways regulate lipolysis in adipocytes.

Authors:  Valéria Ernestânia Chaves; Danúbia Frasson; Nair Honda Kawashita
Journal:  Biochimie       Date:  2011-05-30       Impact factor: 4.079

6.  Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch.

Authors:  Paul Cohen; Julia D Levy; Yingying Zhang; Andrea Frontini; Dmitriy P Kolodin; Katrin J Svensson; James C Lo; Xing Zeng; Li Ye; Melin J Khandekar; Jun Wu; Subhadra C Gunawardana; Alexander S Banks; João Paulo G Camporez; Michael J Jurczak; Shingo Kajimura; David W Piston; Diane Mathis; Saverio Cinti; Gerald I Shulman; Patrick Seale; Bruce M Spiegelman
Journal:  Cell       Date:  2014-01-16       Impact factor: 41.582

7.  Glycine regulates the production of pro-inflammatory cytokines in lean and monosodium glutamate-obese mice.

Authors:  F J Alarcon-Aguilar; Julio Almanza-Perez; Gerardo Blancas; Selene Angeles; Rebeca Garcia-Macedo; Ruben Roman; Miguel Cruz
Journal:  Eur J Pharmacol       Date:  2008-10-09       Impact factor: 4.432

Review 8.  Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities.

Authors:  Michele Cavalera; Junhong Wang; Nikolaos G Frangogiannis
Journal:  Transl Res       Date:  2014-05-10       Impact factor: 7.012

9.  Glycine therapy inhibits the progression of cataract in streptozotocin-induced diabetic rats.

Authors:  Fereshteh Bahmani; S Zahra Bathaie; S Javid Aldavood; Arezou Ghahghaei
Journal:  Mol Vis       Date:  2012-02-11       Impact factor: 2.367

Review 10.  Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.

Authors:  Arunkumar E Achari; Sushil K Jain
Journal:  Int J Mol Sci       Date:  2017-06-21       Impact factor: 5.923

View more
  7 in total

1.  Emerging therapeutic potential of glycine in cardiometabolic diseases: dual benefits in lipid and glucose metabolism.

Authors:  Oren Rom; Luis Villacorta; Jifeng Zhang; Y Eugene Chen; Michael Aviram
Journal:  Curr Opin Lipidol       Date:  2018-10       Impact factor: 4.776

2.  L-Arginine increases AMPK phosphorylation and the oxidation of energy substrates in hepatocytes, skeletal muscle cells, and adipocytes.

Authors:  Wenjuan S Jobgen; Guoyao Wu
Journal:  Amino Acids       Date:  2022-08-16       Impact factor: 3.789

3.  E2F1 Regulates Adipocyte Differentiation and Adipogenesis by Activating ICAT.

Authors:  Jingqing Chen; Yuchen Yang; Shuai Li; Ying Yang; Zhaolai Dai; Fengchao Wang; Zhenlong Wu; Patrick Tso; Guoyao Wu
Journal:  Cells       Date:  2020-04-21       Impact factor: 6.600

4.  Autophagy-induced degradation of Notch1, achieved through intermittent fasting, may promote beta cell neogenesis: implications for reversal of type 2 diabetes.

Authors:  James J DiNicolantonio; Mark McCarty
Journal:  Open Heart       Date:  2019-05-22

5.  Dietary L-arginine supplementation of tilapia (Oreochromis niloticus) alters the microbial population and activates intestinal fatty acid oxidation.

Authors:  Senlin Li; Chao Wang; Zhenlong Wu
Journal:  Amino Acids       Date:  2021-07-02       Impact factor: 3.520

Review 6.  Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure.

Authors:  Mark F McCarty
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

7.  3,5-Diiodo-L-Thyronine (T2) Administration Affects Visceral Adipose Tissue Inflammatory State in Rats Receiving Long-Lasting High-Fat Diet.

Authors:  Giuseppe Petito; Federica Cioffi; Elena Silvestri; Rita De Matteis; Davide Lattanzi; Pieter de Lange; Assunta Lombardi; Maria Moreno; Fernando Goglia; Antonia Lanni; Rosalba Senese
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-12       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.